lung damaging News
-
EPA Proposes New Rule to Protect for ManufacturersConsumers from Harmful Chemicals
Today, EPA is taking action to protect consumers from new uses and imports of the harmful chemicals Toluene Diisocyanates (TDI). These chemicals are currently widely used in residual amounts in the production of polyurethanes and consumer products, such as coatings, elastomers, adhesives, and sealants and can be found in products used in and around homes or schools. Diisocyanates are well known ...
-
EUON Publishes Nanopinion on Addition of Carbon Nanotubes to SIN List
On April 7, 2020, the European Union (EU) Observatory for Nanomaterials (EUON) published a Nanopinion entitled “Carbon Nanotubes — First nanomaterial of high concern on the SIN List.” As reported in our November 27, 2019, blog item, ChemSec added carbon nanotubes to the Substitute It Now (SIN) List in November 2019. According to Dr. Anna Lennquist, Senior Toxicologist, ...
-
Chemicals linked with severe respiratory disease found in common e-cigarette flavors
Diacetyl, a flavoring chemical linked to cases of severe respiratory disease, was found in more than 75% of flavored electronic cigarettes and refill liquids tested by researchers at Harvard T.H. Chan School of Public Health. Two other potentially harmful related compounds were also found in many of the tested flavors, which included varieties with potential appeal to young people such as Cotton ...
-
NDD Medical Technologies reinforces commitment to respiratory therapy professionals with new spirometry training webinars
NDD Medical Technologies (NDD) is the leading provider of pulmonary function equipment, dedicated to the early detection and accurate diagnosis of COPD and other chronic lung diseases. In line with its continued commitment to supporting respiratory professionals—particularly in the wake of the COVID-19 pandemic—NDD is now offering free, live spirometry training sessions to provide ...
-
COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities
Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a ...
By MediPines
-
Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing
Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The CTS Rotea system is the first Gibco instrument for cell therapy processing applications and facilitates workflows from research through GMP clinical development ...
-
Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that three Idylla™ study posters, of which two on the SeptiCyte® RAPID (developed in collaboration with Immunexpress) and one on the Idylla™ SARS-CoV-2 Test (CE-IVD) and Idylla™ SARS-CoV-2/Flu/RSV Panel (CE-IVD), ...
By Biocartis NV
-
Nearly 50,000 Mattresses Sold at Costco Recalled due to the Risk of Possible Mold Exposure
Tens of thousands of mattresses that were sold exclusively at Costco stores have been recalled due to the risk of possible mold exposure. Manufacturer FXI Inc. initially announced the recall of Novaform ComfortGrande 14-inch mattresses and Novaform DreamAway 8-inch mattresses in June and issued a joint press release with the Consumer Product Safety Commission on Thursday. According to FXI, the ...
-
VIDA receives 510(k) clearance for deep learning-based enhancements to its LungPrint solution
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. This clearance further validates the quality and clinical efficacy of the ...
-
Seattle AVM Biotechnology announces second IND for AVM0703: clinical trial permitted to treat COVID-19 and Influenza ARDS with its “supercharged” version of dexamethasone
AVM Biotechnology has received FDA permission to proceed with clinical trials to evaluate its proprietary drug AVM0703 in the treatment of Acute Respiratory Distress Syndrome (ARDS) mediated by COVID-19 or Influenza patients. This is AVM’s second “safe to proceed” clinical trial authorization from the FDA within the past six months and demonstrates the broad potential of ...
-
NDD’s new inline filters offer additional protection against COVID-19 during lung function tests
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has introduced new single patient-use, inline filters for its lung function testing devices, in response to the global COVID-19 pandemic. Ensuring an added level of safety, the new filters can be used with NDD’s ...
-
Health Canada Grants Marketing Authorization for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 Through 11 years With At Least One F508del Mutation
Approximately 500 Canadians ages 6-11 are now eligible for TRIKAFTA®- Vertex has submitted this indication to CADTH & INESSS for Health Technology Assessments- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has granted Marketing Authorization for the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include ...
-
FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19
PITTSBURGH – (BUSINESS WIRE) – April 24, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company Emergency Use Authorization (EUA) designation to the Hemolung® Respiratory ...
-
U.S. EPA determines Phoenix dust storms not solely responsible for poor air quality
The U.S. Environmental Protection Agency (EPA) today announced that it rejected Arizona"s claim that dust storms caused the high pollution readings in Phoenix in 2008, a decision which could have significant implications for the State. Under the Clean Air Act, states must submit plans showing the EPA how the State will meet air quality standards for certain pollutants. Arizona is currently not ...
-
HTG Used for First Time in Congenital Heart Defect Surgery
It was another first for EchoPixel when its Holographic Therapy Guidance (HTG) was used in a congenital heart surgery at Cincinnati Children’s Hospital Medical Center. The procedure was conducted with a new mini 4D transesophageal echocardiography (TEE), which generates real-time ultrasound images and can be used in patients as small as 11 pounds. A life-saving procedure Complete ...
-
Cadmium Is Linked to Increased Breast Cancer Risk
New research indicates that women with higher levels of cadmium in their diets are at a greater risk of developing breast cancer than those who consume less of the heavy metal, reports the LA Times. The study, conducted in Sweden, followed approximately 56,000 women for over 12 years to record their diets and breast cancer diagnoses. The Environmental Protection Agency (EPA) has classified ...
-
EPA helps put America back to work protecting human health and cleaning up the environment
In a move that will boost the economy, create new jobs, build the foundation for long-term economic strength, and protect human health and the environment, the U.S. Environmental Protection Agency (EPA) today announced a national competition for $156 million in funding to jumpstart clean diesel projects through the American Recovery and Reinvestment Act of 2009 (ARRA). The projects will create ...
-
New Study Establishes Cytovale IntelliSep Test in the Rapid Diagnosis of Sepsis
Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune mediated diseases, today announced the publication of a study in the peer-reviewed journal PLOS ONE evaluating its IntelliSep test in the rapid diagnosis of sepsis in the hospital emergency department. Data from the study, “Development and validation of a cellular ...
-
New Study Supports Cytovale IntelliSep Test as Promising Tool to Aid in the Rapid Diagnosis of Sepsis in the Emergency Department
Cytovale, a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune mediated diseases, today announced the publication of a study in the peer-reviewed journal Critical Care Explorations (CCE) evaluating its IntelliSep test as a tool in the rapid diagnosis of sepsis in the hospital emergency department (ED). Data from the study, ...
-
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the publication of results from the Company’s U.S. CytoSorb Therapy in COVID-19 (CTC) retrospective registry in the peer-reviewed journal, Frontiers in Medicine. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you